S. E. Clarke

1.2k total citations
14 papers, 961 citations indexed

About

S. E. Clarke is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, S. E. Clarke has authored 14 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in S. E. Clarke's work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and Analytical Chemistry and Chromatography (2 papers). S. E. Clarke is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and Analytical Chemistry and Chromatography (2 papers). S. E. Clarke collaborates with scholars based in United Kingdom and United States. S. E. Clarke's co-authors include R J Chenery, J. C. Bloomer, Phil Jeffrey, Sandra Baldwin, Graeme Smith, Andrew W. Harrell, Joann Sanders–Loehr, Amin Rostami‐Hodjegan, Farshid Ghanbari and Chris Lennard and has published in prestigious journals such as Applied and Environmental Microbiology, British Journal of Clinical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

S. E. Clarke

14 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. E. Clarke United Kingdom 12 597 317 236 118 92 14 961
Martine Bourrié France 10 514 0.9× 337 1.1× 221 0.9× 96 0.8× 79 0.9× 13 890
Päivi Taavitsainen Finland 18 722 1.2× 318 1.0× 226 1.0× 184 1.6× 77 0.8× 26 1.1k
A. B. Renwick United Kingdom 24 857 1.4× 341 1.1× 347 1.5× 137 1.2× 59 0.6× 34 1.4k
G. Gordon Gibson United Kingdom 18 710 1.2× 370 1.2× 489 2.1× 101 0.9× 77 0.8× 38 1.4k
M Veronese Australia 14 788 1.3× 379 1.2× 440 1.9× 116 1.0× 114 1.2× 21 1.2k
Yasuhiro Masubuchi Japan 17 783 1.3× 344 1.1× 329 1.4× 152 1.3× 48 0.5× 39 1.2k
Tian J. Yang United States 15 721 1.2× 365 1.2× 314 1.3× 125 1.1× 88 1.0× 28 1.2k
R. Böcker Germany 19 509 0.9× 284 0.9× 275 1.2× 153 1.3× 76 0.8× 51 1.1k
Deborah Dunbar United States 18 789 1.3× 510 1.6× 274 1.2× 145 1.2× 73 0.8× 25 1.3k
J. A. Hinson United States 17 737 1.2× 262 0.8× 301 1.3× 106 0.9× 115 1.3× 26 1.3k

Countries citing papers authored by S. E. Clarke

Since Specialization
Citations

This map shows the geographic impact of S. E. Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. E. Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. E. Clarke more than expected).

Fields of papers citing papers by S. E. Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. E. Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. E. Clarke. The network helps show where S. E. Clarke may publish in the future.

Co-authorship network of co-authors of S. E. Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of S. E. Clarke. A scholar is included among the top collaborators of S. E. Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. E. Clarke. S. E. Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ghanbari, Farshid, K Rowland‐Yeo, J. C. Bloomer, et al.. (2006). A Critical Evaluation of the Experimental Design of Studies of Mechanism Based Enzyme Inhibition, with Implications for In Vitro-In Vivo Extrapolation. Current Drug Metabolism. 7(3). 315–334. 95 indexed citations
2.
Clarke, S. E. & Phil Jeffrey. (2001). Utility of metabolic stability screening: comparison ofin vitroandin vivoclearance. Xenobiotica. 31(8-9). 591–598. 92 indexed citations
3.
Clarke, S. E.. (1998). In vitro assessment of human cytochrome P450. Xenobiotica. 28(12). 1167–1202. 104 indexed citations
4.
Bloomer, J. C., S. E. Clarke, & R J Chenery. (1997). In vitro identification of the P450 enzymes responsible for the metabolism of ropinirole.. PubMed. 25(7). 840–4. 33 indexed citations
5.
Poon, Grace K., et al.. (1996). Rapid Screening of Taxol Metabolites in Human Microsomes by Liquid Chromatography/ Electrospray Ionization-Mass Spectrometry. Rapid Communications in Mass Spectrometry. 10(10). 1165–1168. 23 indexed citations
6.
Bloomer, J. C., S. E. Clarke, & R J Chenery. (1995). Determination of P4501A2 activity in human liver microsomes using [3-14C-methyl]caffeine. Xenobiotica. 25(9). 917–927. 17 indexed citations
7.
Baldwin, Sandra, et al.. (1995). Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica. 25(3). 261–270. 269 indexed citations
8.
Clarke, S. E., Andrew W. Harrell, & R J Chenery. (1995). Role of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver.. Drug Metabolism and Disposition. 23(2). 251–254. 75 indexed citations
9.
Clarke, S. E., Nigel Austin, J. C. Bloomer, et al.. (1994). Metabolism and disposition of14C-granisetron in rat, dog and man after intravenous and oral dosing. Xenobiotica. 24(11). 1119–1131. 24 indexed citations
10.
Clarke, S. E., et al.. (1994). Characterization of the inhibition of P4501A2 by furafylline. Xenobiotica. 24(6). 517–526. 66 indexed citations
11.
Harrell, Andrew W., et al.. (1994). Use of rat and human in vitro systems to assess the effectiveness and enzymology of deoxyguanine analogs as prodrugs of an antiviral agent.. Drug Metabolism and Disposition. 22(2). 189–193. 2 indexed citations
12.
Harrell, Andrew W., et al.. (1994). Use of rat and human in vitro systems to assess the effectiveness and enzymology of deoxy-guanine analogues as prodrugs of an antiviral agent.. Drug Metabolism and Disposition. 22(1). 124–128. 10 indexed citations
13.
Clarke, S. E., et al.. (1994). Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of granisetron.. British Journal of Clinical Pharmacology. 38(6). 557–566. 75 indexed citations
14.
Clarke, S. E., et al.. (1987). Induction of siderophore activity in Anabaena spp. and its moderation of copper toxicity. Applied and Environmental Microbiology. 53(5). 917–922. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026